Correction : BMC Med 21, 476 (2023)
https://doi.org/10.1186/s12916-023-03182-1
Upon reviewing the published manuscript [1], the authors identified a errors affecting Figure 2 that require clarification:
1. In Figure 2C, the wild-type (WT) and mutated TP53 cell lines were incorrectly colour-coded.
2. In Figure 2D and 2E, the labels for TP53 mutated cells and wild type were inadvertently inverted.
3. There is a typographical error in the caption of Fig. 2, where the word "XX" should be replaced with "24".
The corrected version of Figure 2 and its caption can be viewed ahead for reference.
In addition, the following line in the main text should be changed from:
"As depicted in Fig. 2C, seven of the 24 cell lines within this dataset harbour a missense mutation in the TP53 gene, while all other cell lines retain the wild-type (WT) TP53 form."
to:
"As depicted in Figure 2, seven of the 24 cell lines within this dataset retain the wild-type (WT) TP53 form, while all other cell lines harbour a missense mutation in the TP53 gene."
Reference
- 1.Pellecchia S, et al. Predicting drug response from single-cell expression profiles of tumours. BMC Med. 2023;21:476. doi: 10.1186/s12916-023-03182-1. [DOI] [PMC free article] [PubMed] [Google Scholar]